Cite
GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity
MLA
Lin, Jieru Egeria, et al. “GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity.” Department of Pharmacology and Experimental Therapeutics Faculty Papers, 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn856331778&authtype=sso&custid=ns315887.
APA
Lin, J. E., Snook, A. E., Li, P., Stoecker, B. A., Kim, G. W., Magee, M. S., Mejia Garcia, A. V., Valentino, M. A., Hyslop, T., Schulz, S., & Waldman, S. A. (2012). GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity. Department of Pharmacology and Experimental Therapeutics Faculty Papers.
Chicago
Lin, Jieru Egeria, Adam Eugene Snook, Peng Li, Brian Arthur Stoecker, Gilbert Won Kim, Michael Sullivan Magee, Alex Vladimir Mejia Garcia, et al. 2012. “GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity.” Department of Pharmacology and Experimental Therapeutics Faculty Papers. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn856331778&authtype=sso&custid=ns315887.